| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.23 | 9e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |